Skip to content
Institutional Biosafety Committee Minutes for February 12, 2026

Institutional Biosafety Committee Minutes for February 12, 2026

A meeting of Southern Research’s Institutional Biosafety Committee convened on Thursday,
12 February 2026, in Birmingham, Alabama.

The following participants were present:

Kayton Cherry, Voting Participant
Enatra Hale, Voting Participant
Lamar Jones, Voting Participant
Mark Jackson (via Teams), Voting Participant
Synthia Mayfield, Voting Participant
Steven Orr, Voting Participant
La’Wanda Parker, Voting Participant
James Toomey, Voting Participant
Amanda Haley (via Teams), Visitor
Miranda Nebane, Visitor
Christina Humphries, Ex-Officio

  1. Review and Approval of Meeting Agenda
    The Chairperson called the meeting to order. The Chairperson asked the committee to
    review the agenda. A motion was made to approve. A second was made and by voice vote
    the agenda was approved.
  2. Review and Approval of Previous Meeting Minutes
  • 08 January 2026 – A motion was made to approve. A second was made, and by voice
    vote the minutes were approved.
  • 22 January 2026 – A motion was made to approve. A second was made, and by voice
    vote the minutes were approved as corrected.
  1. New Business
  • BSO Notes/OSP Reportable Incidents Report –
    A report was sent to the NIH regarding a blood spill from study tissues in the BSL-3
    on 18 December 2025. The NIH did not require any follow-up information.
  1. Review and Approval of BPRs and Amendments
    R24-03-007NS, Amendment 10
    Title: Core Non-Infectious HTS Assays
    RS: Miranda Nebane-Ngwa
    IBC reviewed, no comments or contingencies were received. A motion was made to
    approve as submitted, a second was made, and by voice vote the BPR amendment was
    approved.
    INSTITUTIONAL BIOSAFETY COMMITTEE
    Minutes, Page 2 of 2
  • Agent Name: human FGFR4 and PLC-γ cDNA Inserts
  • Agent Characteristics: No change from core
  • Containment Conditions: BSL-2
  • Sources of the Inserted DNA Sequences: commercially supplied
  • Foreign Gene Expression: Hek293t cells express fusion protein
  • Protein Expressed: fusion proteins
  • Applicable Section(s) of the NIH Guidelines: Section III D 3
  • Types of Manipulations Planned: Same as Core
    BPR Amendments Approved Via Biosafety Officer Review:
    None

Adjourn

Next Meeting
The next Institutional Biosafety Committee meeting is scheduled for Thursday,
12 March 2026 at 11:15 a.m. in Birmingham.